Insider Transactions in Q3 2023 at Jaguar Health, Inc. (JAGX)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 14
2023
|
Anula Jayasuriya Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,568
+49.38%
|
-
|
Aug 14
2023
|
Pravin R Chaturvedi Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
204,192
+49.86%
|
-
|
Aug 14
2023
|
James J Bochnowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
76,613
+49.27%
|
-
|
Aug 14
2023
|
John Micek Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,568
+45.94%
|
-
|
Aug 14
2023
|
Jonathan B. Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,568
+49.53%
|
-
|
Aug 14
2023
|
Lisa A Conte CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
383,605
+49.74%
|
-
|
Aug 14
2023
|
Steven R. King Officer |
BUY
Grant, award, or other acquisition
|
Direct |
159,168
+49.85%
|
-
|
Aug 14
2023
|
Carol R. Lizak Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
142,088
+49.88%
|
-
|
Aug 14
2023
|
Jonathan S. Wolin Chief of Staff, CCO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
196,628
+49.87%
|
-
|
Jul 01
2023
|
Anula Jayasuriya Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,718
+50.0%
|
-
|